There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.

After Netflix ( NFLX 2.55%) walked away from a potential acquisition deal earlier in the year with Warner Bros Discovery, Q1 ...

Marvell and Lumentum didn’t just bounce with the market after the Iran ceasefire. They snapped back because of their role in ...

Rick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most ...

After a four-year downturn, early signs in 2026 suggest biotech funding is stabilizing. Danaher is guiding for 3%–6% revenue ...

What's more, the SSA considers you to be "retired" if your monthly earnings are $2,040 or less. So, this means that even if ...

Arm's first in-house AI chip could reshape its whole business model, but with the stock already expensive, investors need to ...

Investing in small-cap stocks can be a trade-off between risk and growth opportunity. The Russell 2000 is the primary index ...

On top of that, this Buffett stock pick pays a dividend that's yielding a hefty 4.3%. Sirius may no longer be the disruptor ...

These three underappreciated growth stocks have real moats, long runways, and the potential to compound for years while the ...

Joby Aviation is getting closer to real commercial progress, but the biggest test is still ahead, and that could decide where ...

Tesla just built 50,000 unsold cars and missed deliveries. Is this a temporary setback, or the first real sign that the ...